Clinical Trial Update: Therapeutic Options for CRAB [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating therapeutic options for carbapenem-resistant Acinetobacter baumannii infections and sepsis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Sepsis

Snippet

Sponsor: Clinical Hospital Centre Zagreb | Conditions: Infections, Bacterial, Sepsis Bacterial | Phase 4 | Status: RECRUITING